THRA and breast carcinoma: Furthermore, this research group investigated the involvement of other nuclear receptors, such as vitamin D receptor, retinoid X receptor, thyroid hormone receptor alpha 1 (THRα1), and thyroid hormone receptor alpha 2 (THRα2), in the prognosis of MF/MC breast cancer patients.11, 33